Navigation Links
Michael DeMane Joins Thomas, McNerney & Partners as Senior Advisor

Former Medtronic Chief Operating Officer joins Minneapolis office.

MINNEAPOLIS, April 3 /PRNewswire/ -- Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, today announced that Michael DeMane has joined as Senior Advisor in the firm's Minneapolis office. From 2000 to 2008, Mr. DeMane held various senior positions at Medtronic Inc.'s (NYSE: MDT) U.S. and global operations, most recently as its Chief Operating Officer.

"Michael is a proven leader in the medical device industry with an unbroken record of global operating success," said Pete McNerney, Partner. "His extensive knowledge and industry contacts will be a valuable addition to our investment team, both in working with our existing portfolio and in reviewing potential new investments."

Mr. DeMane has more than 25 years of global medical device experience. Prior to his role as Chief Operating Officer at Medtronic, he served as Senior Vice President and President, Europe, Canada, Latin America and Emerging Markets. Previously he was Senior Vice President and President, Spinal, ENT and Navigation, Medtronic's fastest growing business sector, where he was responsible for growing the acquired businesses of Sofamor Danek, Xomed and Surgical Navigation Technologies. Prior to joining Medtronic, Mr. DeMane was President, Interbody Technologies, a division of Sofamor Danek and he held various senior positions at Smith & Nephew, Inc. including Managing Director for operations in Australia and New Zealand and President of the Orthopedic Implant Division. "Thomas, McNerney & Partners has extensive investment experience and wide contacts in the medical technology industry," said Mr. DeMane. "I look forward to assisting them with their portfolio companies and investment process."

About Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies at all stages of development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations. The firm is targeting investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. The firm has offices in Minneapolis, Stamford and San Francisco. For further information, please visit

SOURCE Thomas, McNerney & Partners, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
2. HealthWorldWeb Adds Michael Millenson and J.D. Kleinke to Board of Advisors
3. Fish health claims may cause more environmental harm than good: UBC-St. Michaels researchers
4. Michael J. Fox Foundation Joins Effort to Recruit 10,000 People With Parkinsons Disease to New Web-Based PD Research Community
5. Rehab Specialist, Michael Fisher, Joins Fast - Growing Alliance Seating & Mobility in North Carolina
6. NewCardio Elects Michael E. Hanson to Board of Directors
7. Michael Forte Joins CONNEXION Healthcare as Chief Operations Officer
8. President Michael Del Chiaro Interviewed by for ecommerce Expertise
9. ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinsons Disease Research to Develop Tools for Imaging Alpha-Synuclein Aggregation in Living Parkinsons Brain
10. Michael L. Parks, MD, Elected to the American Academy of Orthopaedic Surgeons Board of Directors
11. American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer
Post Your Comments:
(Date:10/13/2017)... , ... October 13, 2017 , ... As health professionals ... known as “patient engagement.” The patient is doing more than filling out a survey; ... , “There is an increasing emphasis in health care and research on the importance ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: